October 28, 2016 5 more charged with drug conspiracy in Middle Tennessee overdose outbreak Five more people are facing federal drug charges in a fentanyl overdose outbreak that killed two people in Tennessee over 24 hours this summer, U.S. Attorney David Rivera announced Thursday.
October 28, 2016 AstraZeneca pauses 2 cancer drug trials' enrollment due to bleeding AstraZeneca's high hopes for cancer immunotherapy were dented on Thursday as the recruitment of new patients with head and neck cancer into two clinical studies was put on hold, following instances of bleeding.
October 28, 2016 Have a kid with migraines? Sugar pills work as well as drugs Sugar pills worked as well at preventing kids' migraines as two commonly used headache medicines, but had fewer side effects, in a study that may lead doctors to rethink how they treat a common ailment in children and teens.
October 25, 2016 FDA approves Merck's lung cancer drug as first-line treatment Merck & Co Inc on Monday said the U.S. Food and Drug Administration has approved its immunotherapy Keytruda for use in certain previously untreated lung cancer patients, making it the only approved first-line treatment.
October 22, 2016 The right way to take melatonin supplements, according to a sleep doc Jet lag always seems to get the best of me when I travel.
October 21, 2016 Placebo pills may help with back pain People who take a placebo, sometimes called a "dummy pill," along with their regular over-the-counter pain medication may get additional relief from their low-back pain, even if they know the placebo is essentially a dud, a new study finds
October 20, 2016 Lawmakers demand answers on leukemia drug price hikes Two top lawmakers on Thursday demanded information from a drug company that has raised prices on a leukemia drug, calling increases of tens of thousands of dollars a sign the company puts profits before patients.
October 20, 2016 Lilly's soft tissue sarcoma treatment gets US approval The U.S. Food and Drug Administration on Wednesday approved Eli Lilly and Co's treatment for adults with advanced soft tissue sarcoma (STS).
October 20, 2016 Roche's lung cancer drug wins US approval Swiss drugmaker Roche Holding AG's new immunotherapy, Tecentriq, won approval on Tuesday from U.S. health regulators as a second-line lung cancer treatment, a decision seen likely to erode Bristol-Myers Squibb's position in this hotly contested market.
October 20, 2016 4-year-old boy hospitalized after taking too many supplements If you’ve ever been wary of popping too many supplements, this story may confirm your concerns: A new report published in the BMJ documents the case of a four-year-old boy who became severely ill after taking a slew of alternative medicines prescribed by a naturopath.
